BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Africa/Lagos
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0100
TZNAME:WAT
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20230312T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20231105T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240223
DTEND;VALUE=DATE:20240224
DTSTAMP:20240218T175243Z
CREATED:20240218T174811Z
LAST-MODIFIED:20240218T175243Z
UID:60021-1708646400-1708732799@globalbiodefense.com
SUMMARY:Rapid Access to Products in Development (RAPID) Virtual Industry Day
DESCRIPTION:A Joint Industry Day for the Rapid Access to Products in Development (RAPID) program to be held virtually on 23 Feb 2024. \nThe Joint Program Executive Office for Chemical\, Biological\, Radiological\, and Nuclear Defense\, Enabling Biotechnologies (JPEO-CBRND-EB)\, develops\, manufactures and delivers safe and effective Medical Countermeasures (MCMs) for preparedness\, prevention\, protection\, response\, and recovery from CBRN threats. \nThe Rapid Access to Products in Development (RAPID) program is an integrated defense system composed of both physical MCM storage and fielding capabilities and a readily accessible information warehouse and sharing system (the RAPID Database). \nThe purpose of this Industry Day is to identify industry partners and capabilities to develop a RAPID Database capable of storing and organizing complex data and information related to CBRN MCMs such that it is intuitively accessible by a variety of end users during urgent planning and response situations. \nThe Database is intended to provide actionable information to assist CCMD-level decision makers when evaluating a RAPID MCM for potential administration to US warfighters; and JPEO- and CBDP-level decision makers when determining portfolio investment strategies or rapid response adjustments based on changing circumstances. \nThis Industry Day will include presentation by JPL EB as well as opportunities for industry partners to present their capabilities in one-on-one breakout sessions with representatives from the Government agencies. Industry partners will update Government stakeholders\, partners\, and end users on current efforts and capabilities. \nCompanies that wish to attend must register no later than 19 Feb 2024. More information is available at SAM.gov Notice ID W911SR-24-S-RAPID.
URL:https://globalbiodefense.com/event/medical-countermeasures-rapid-access-to-products-in-development-rapid-virtual-industry-day/
LOCATION:
CATEGORIES:Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240224
DTEND;VALUE=DATE:20240229
DTSTAMP:20240202T041837Z
CREATED:20240202T041825Z
LAST-MODIFIED:20240202T041837Z
UID:59826-1708732800-1709164799@globalbiodefense.com
SUMMARY:Pittcon 2024
DESCRIPTION:Pittcon 2024 will be held 24-28 February 2024 in San Diego\, California. \nThis 75th edition of the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy (Pittcon) is for anyone who develops\, buys\, or sells laboratory equipment\, performs physical or chemical analyses\, develops analysis methods\, or manages these scientists. \nPittcon is a dynamic\, international conference and exposition on laboratory science\, a venue for presenting the latest advances in analytical research and scientific instrumentation\, and a platform for continuing education and science-enhancing opportunity. \nHighlighted agenda and short course topics include: \n\nPoint-of-use Raman spectroscopic characterization of pathogens\nThermally Robust Biomimetic Substitutes to Metalloenzymes for Rapid Hydrolytic Degradation and Electrochemical Field Detection of Chemical Warfare Agents\nStrategy and Instrumentation for Safety Protection of Personnel Working on Ships for Maritime Chemical Threat Assessment and Response\nChemical Spill and Chemical Fires in East Palestine\, Ohio: Chemical Fate and Exposure Pathways\nField-deployable Biosensors for Rapid Characterization of Microbiomes\nNuclear Forensics: Analytical Chemistry Combating Nuclear Terrorism\nLabel-Free Lab on a Chip Device for Purification and Characterization of Small Extracellular Vesicles\nFighting Bacteria with Micromotors\nTargeted and Untargeted Analysis for Rapid Response Following Disasters\nOvercoming Challenges in Pharmaceutical Development Using Novel Analytical Approaches\nApplication of 2DLC to novel therapeutics\nModified Membranes for Rapid Monoclonal Antibody Capture\, Digestion\, and Analysis\nBiomarker Detection using Microfluidics\nHandheld Near-Infrared Spectroscopy: Anywhere\, Anytime by Anybody\nIntroduction to Quantitative Spectroscopy for Near Infrared and Raman Instrumentation\nIntroduction to Solid State NPR Spectroscopy\nFundamentals and Recent Developments of X-Ray Photoelectron Spectroscopy\nThe Art of Structure Elucidation of Small Molecules Using Mass Spectrometry\nIndustrial Problem-Solving Using Surface FTIR Techniques\nEffective Technical Communication for Analytical Chemists\nMethod Translation and Modelling in Gas Chromatography\nThermal Gel Electrophoresis to Streamline Biological Characterizations\n\nPlease visit the Pittcon 2024 website for more information and to register to attend.
URL:https://globalbiodefense.com/event/pittcon-2024/
LOCATION:San Diego Convention Center\, 111 West Harbor Drive\, San Diego\, CA 92101\, 92101\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240224T190000
DTEND;TZID=America/New_York:20240224T213000
DTSTAMP:20240202T001437Z
CREATED:20240202T001437Z
LAST-MODIFIED:20240202T001437Z
UID:59824-1708801200-1708810200@globalbiodefense.com
SUMMARY:An Enemy of the People: A Public Health Project
DESCRIPTION:LabX – a program of the National Academy of Sciences – in partnership with Cultural Programs of the NAS\, present An Enemy of the People\, featuring performances by acclaimed actors David Strathairn (Nomadland)\, Keith David (Nope)\, Brían F. O’Byrne (The Wonder)\, and Jay O. Sanders (True Detective) as well as public health leaders Anthony Fauci (Former Director\, National Institute of Allergy and Infectious Diseases)\, Francis Collins (Former Director\, National Institutes of Health)\, Keshia Pollack Porter (Chair\, Department of Health Policy and Management\, Johns Hopkins Bloomberg School of Public Health)\, Gloria Addo-Ayensu (Director of Health\, Fairfax County Health Department)\, Ruth Faden (Founder\, Johns Hopkins Institute of Bioethics)\, Victor Dzau (President\, National Academy of Medicine)\, Nancy Kass (Deputy Director of Public Health at the Johns Hopkins Institute of Bioethics)\, Vivian Pinn (Senior Scientist Emerita at the NIH Fogarty International Center) and more! \nTogether they will perform dramatic readings of scenes from Henrik Ibsen’s 1882 play An Enemy of the People to help frame powerful\, guided audience discussions aimed at generating connection\, understanding\, compassion\, moral repair\, and much-needed healing. \nAn Enemy of the People tells the story of a doctor who discovers the water supply in his small\, rural town has been poisoned by a tannery. Despite his efforts to convey the truth to the public\, the doctor fails to save his community from environmental disaster and is ultimately scapegoated for his whistleblowing. An Enemy of the People was first performed in Norway in 1882\, and yet it speaks to the present moment as if it were written for our times — to the corrosive influence of power and money in politics\, the distortions of the media\, and the many other challenges to public health in our culture today\, especially during times of crisis. \nJoin NAS for an evening of profound exploration\, thought-provoking dialogue\, and shared intellectual engagement. \nPresented by Theater of War Productions and LabX – A Program of the National Academy of Sciences in partnership with Cultural Programs of the National Academy of Sciences. Adapted\, directed\, and facilitated by Bryan Doerries. \nPlease visit the National Academies’ An Enemy of the People: A Public Health Project to register to attend.
URL:https://globalbiodefense.com/event/an-enemy-of-the-people-a-public-health-project/
LOCATION:National Academies of Sciences\, 2101 Constitution Ave NW\, Washington\, DC\, 20418\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240228
DTEND;VALUE=DATE:20240301
DTSTAMP:20240226T215053Z
CREATED:20240226T215042Z
LAST-MODIFIED:20240226T215053Z
UID:60125-1709078400-1709251199@globalbiodefense.com
SUMMARY:Meeting of the Advisory Committee on Immunization Practices (ACIP)
DESCRIPTION:The CDC’s Advisory Committee on Immunization Practices (ACIP) will convene 28-29 February 2024 in Atlanta\, GA and via webcast. \nThe ACIP develops recommendations for U.S. immunizations\, including ages when vaccines should be given\, number of doses\, time between doses\, and precautions and contraindications. \nThe agenda will include the following: \n\nUpdate on chikungunya vaccine licensure and review of proposed policy options for chikungunya vaccine use among U.S. adults traveling abroad\, laboratory workers\, and pregnant and breastfeeding persons\nGuidance to use Td vaccine for those instances when receipt of the pertussis component is contraindicated\nCOVID-19 vaccination coverage\, effectiveness and economic analysis of additional dose recommendations\nNext steps for the COVID-19 vaccine program\nInterim estimates of 2023-24 seasonal influenza vaccine effectiveness\nSafety of LAIV4 in children with asthma\nInfluenza B/Yamagata update\nPolio Work Group deliberations on potential use of nOPV2 as an outbreak control measure in the US\nClinical considerations for children who received fractional dose inactivated polio vaccine (fIPV) in other countries\nPost-marketing safety surveillance of older adult RSV vaccination\nPreliminary Analysis of Guillain-Barré Syndrome (GBS) following RSV vaccination among adults 65 years and older\nOverview of Moderna’s investigational RSV Vaccine (mRNA-1345) in adults ≥60 years of age\nRevising the adolescent Meningococcal vaccine schedule\nCurrent epidemiology of invasive pneumococcal disease and pneumococcal vaccine coverage in adults\nPreliminary findings of the Pneumococcal pNeumonia Epidemiology\, Urine serotyping\, and Mental Outcomes (PNEUMO) US study\nBackground on invasive Hib disease and vaccination among American Indian and Alaska Native Populations\n\nThe meeting will be held on February 28\, 2024\, from 8 a.m. to 5 p.m.\, EST and February 29\, 2024\, from 8 a.m.\nto 3 p.m.\, EST (times subject to change). \nPlease visit the CDC’s Advisory Committee on Immunization Practices for the latest information. No registration is required to watch the webcasts.
URL:https://globalbiodefense.com/event/meeting-of-the-advisory-committee-on-immunization-practices-acip/
LOCATION:https://video.ibm.com/channel/VWBXKBR8af4
CATEGORIES:Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240304
DTEND;VALUE=DATE:20240306
DTSTAMP:20240201T221507Z
CREATED:20240201T221507Z
LAST-MODIFIED:20240201T221507Z
UID:59820-1709510400-1709683199@globalbiodefense.com
SUMMARY:Assessing the Burden and Potential Strategies to Address Antimicrobial Resistance
DESCRIPTION:A National Academies’ committee of experts will convene 4-5 March 2024 for a workshop to discuss the burden of antimicrobial resistance and strategies to address AMR challenges. \nParticipants can attend the workshop virtually and submit questions to speakers. The event will take place 12:00 PM – 4:15 PM ET each day. \nThere is broad recognition of the critical need to address the development and spread of antimicrobial resistance (AMR). A global\, systematic analysis estimates that AMR infections lead to 1.27-4.95 million deaths per year\, and resistant bacterial infections are now a leading cause of neonatal mortality worldwide. While scientific and economic challenges have long hindered development of novel antimicrobials\, recent pull incentives have been proposed to support a sustainable market and investment in new antimicrobials. These recent discussions provide a timely opportunity to explore the current burden of AMR and discuss potential future policies in the context of new scientific innovations. \nHighlighted agenda topics include: \nMonitoring AMR in Plants\, Animals\, and the Environment \n\nModerator: Ramanan Laxminarayan\, One Health Trust\nEnvironmental and Wastewater Surveillance: Joakim Larsson\, University of Gothenburg\nAMR in Livestock and Food Systems (or Crops): Paul Plummer\, Iowa State University College of Veterinary Medicine\nRole of AMR in Cross-cutting Conferences – Experience from COP28: Haileyesus Getahun\, World Health Organization\n\nMaking Meaning from Metrics: What’s at Stake? \n\nModerator: Chris Braden\, U.S. Centers for Disease Control and Prevention\nImpact of AMR – what’s not being captured: Dawn Sievert\, U.S. Centers for Disease Control and Prevention\nModeling Prevention Strategies: Joseph Lewnard\, University of California\, Berkeley\n\nImpact of AMR Across Medical Practice \n\nModerator: Helen Boucher\, Tufts University\nSkilled Nursing Facilities: Susan Huang\, University of California\, Irvine\nSurgery: Shawn Rangel\, Boston Children’s Hospital\nOncology: John Wingard\, University of Flo\n\nStewardship \n\nOutpatient or Telemedicine Perspective: Kristin Ray\, UPMC Children’s Hospital of Pittsburgh\nAdvanced Diagnostics: Robin Patel\, Mayo Clinic\nPediatric Antimicrobial Stewardship (Hospital Perspective): Ritu Banerjee\, Vanderbilt University Medical Center\n\nAccess \n\nProtecting Pharmaceutical Supply Chains in LMICs: Anthony McDonnell\, Center for Global Development\nImproving Access and Balancing Stewardship in LMICs: Jennifer Cohn\, Global Antibiotic Research & Development Partnership\nSustainable Use of Available Medicines: Esmita Charani\, University of Cape Town\n\nInnovation \n\nSynthetic Biology and Artificial Intelligence: James Collins\, Massachusetts Institute of Technology\nConsiderations for Successful Public-Private Partnership Model in Antibiotic Development: Ken Duncan\, Bill & Melinda Gates Foundation\nSupporting New Antimicrobials in Clinical Use: Ramy Elshaboury\, Massachusetts General Hospital\n\nPlease visit NASEM’s Assessing the Burden and Potential Strategies to Address Antimicrobial Resistance: A Workshop for more information. \n 
URL:https://globalbiodefense.com/event/assessing-the-burden-and-potential-strategies-to-address-antimicrobial-resistance/
LOCATION:https://www.nationalacademies.org/event/41831_03-2024_assessing-the-burden-and-potential-strategies-to-address-antimicrobial-resistance-a-workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240304
DTEND;VALUE=DATE:20240306
DTSTAMP:20240301T192959Z
CREATED:20240301T192959Z
LAST-MODIFIED:20240301T192959Z
UID:60470-1709510400-1709683199@globalbiodefense.com
SUMMARY:25th Meeting of the Malaria Policy Advisory Group (MPAG)
DESCRIPTION:The open sessions of the WHO’s 25th meeting of the Malaria Policy Advisory Group (MPAG) will take place in Yaoundé\, Cameroon on 4–5 March 2024. Technical partners\, UN agencies\, and other members of the global malaria community are welcome to register for online participation only. \nHighlighted agenda items include: \n\nUpdate on malaria vaccines\nUpdate on subnational tailoring of malaria interventions and strategies\nGuiding principles for prioritizing malaria interventions in resource-constrained country contexts to achieve maximum impact (draft document) + summary overview\nBiological threats to malaria vector interventions\nUpdate on Gavi supported malaria learning agenda\nGuiding principles for prioritization overview\nStrategy to respond to antimalarial drug resistance in Africa – updates and identification of needs\nUpdate on development of guidelines recommendations on tafenoquine\, primaquine and near-patient G6PD diagnostic test to support radical cure of P. vivax\nUpdate on malaria elimination\, including zoonotic malaria\n\nPlease visit the WHO’s Malaria Policy Advisory Group Meeting webpage to register.
URL:https://globalbiodefense.com/event/25th-meeting-of-the-malaria-policy-advisory-group-mpag/
LOCATION:Yaoundé\, Cameroon\, Yaoundé\, Cameroon
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240306
DTEND;VALUE=DATE:20240309
DTSTAMP:20240301T194704Z
CREATED:20240301T194529Z
LAST-MODIFIED:20240301T194704Z
UID:60473-1709683200-1709942399@globalbiodefense.com
SUMMARY:2024 St. Jude-PIDS Pediatric Infectious Diseases Research Conference
DESCRIPTION:The 23rd annual St. Jude-PIDS Pediatric Infectious Diseases Research Conference will be March 6-8\, 2024 in Memphis\, TN and virtually. \nHighlighted agenda items include: \n\nDengue: From Local Risk to Global Epidemics\nA Journey in Dengue Vaccine Research\nA Renaissance of Novel Antifungal Agents: Learning from Expanded Use in Pediatric Patients\nA One Health Approach to Antibiotic Resistant Gram-Negative Bacteria in the Community\nWhat’s New and on the Horizon for Pneumococcal and RSV Vaccines in Children\n\nPlease visit the St. Jude-PIDS Pediatric Infectious Diseases Research Conference event website for more information and to register for the conference.
URL:https://globalbiodefense.com/event/2024-st-jude-pids-pediatric-infectious-diseases-research-conference/
LOCATION:The Peabody Memphis\, 149 Union Ave\, Memphis\, TN\, 38103\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240306T080000
DTEND;TZID=America/New_York:20240306T090000
DTSTAMP:20240301T202233Z
CREATED:20240301T202233Z
LAST-MODIFIED:20240301T202233Z
UID:60478-1709712000-1709715600@globalbiodefense.com
SUMMARY:Lessons on Urban Mass Drug Administration Towards Elimination of Neglected Tropical Diseases
DESCRIPTION:This session will provide examples of innovative strategies that have been used to tailor and strengthen mass drug administration in urban contexts for the control and elimination of neglected tropical diseases. \nA group of diverse speakers will highlight the latest implementation experience on promising practices and approaches that can be applied to varied urban contexts. Session participants will help specify and prioritize operational research gaps for urban MDA. \nSpeakers: \n\nDr. Jonathan King\, WHO\nProfessor Benjamin Koudou\, CSRS\nDr. Muhammad Babar Khan\, RTI International\nMarie Maud Jean\, WI-HER\nRajshree Das\, PCI India\n\nOrganized by COR-NTD\, Act to End NTDs East\, USAID and RTI International
URL:https://globalbiodefense.com/event/lessons-on-urban-mass-drug-administration-towards-elimination-of-neglected-tropical-diseases/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240306T140000
DTEND;TZID=America/New_York:20240306T150000
DTSTAMP:20240301T223634Z
CREATED:20240301T223634Z
LAST-MODIFIED:20240301T223634Z
UID:60493-1709733600-1709737200@globalbiodefense.com
SUMMARY:NACCHO Presents: Long COVID Overview with CDC
DESCRIPTION:Please join NACCHO and CDC for a presentation on long COVID featuring Priti Patel\, MD\, MPH\, and Sharon Saydah\, PhD\, MHS\, from CDC’s National Center for Immunization and Respiratory Diseases. \nThe webinar will provide an overview of long COVID\, explore existing research\, and include time for a Q&A. \nInitial questions for the Q&A may be submitted when registering.
URL:https://globalbiodefense.com/event/naccho-presents-long-covid-overview-with-cdc/
LOCATION:https://naccho.zoom.us/webinar/register/WN_GmQhefy3SaqaW_xses1ieg#/registration
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240307
DTEND;VALUE=DATE:20240311
DTSTAMP:20240111T184249Z
CREATED:20240111T180627Z
LAST-MODIFIED:20240111T184249Z
UID:59600-1709769600-1710115199@globalbiodefense.com
SUMMARY:CUGH 2024 - Consortium of Universities for Global Health
DESCRIPTION:The Consortium of Universities for Global Health will convene the CUGH 2024 Conference on 7 March 2024 in Los Angeles\, CA and via satellite sessions. \nFree and Open to the public Satellite Sessions begin at 8:00am on March 7\, 2024. Conference will begin at 4:30pm on March 7\, 2024. \nHighlighted agenda items include: \nDecolonizing the Pandemic Fund: Charting an Equitable Path Forward \nRobust and equitable financing for pandemic prevention\, preparedness\, response\, and reconstruction (PPPRR) is essential to prevent global health crises like COVID-19. The World Bank launched the Pandemic Fund to address this. Yet\, the Fund grapples with acquiring sufficient capital for PPPRR in low—middle— income countries and addressing policies that limit transparent and efficient fund allocation. For this panel\, we’ll gather health financing specialists\, including a Pandemic Fund board member from the Global South’s civil society. We’ll discuss how civil society can improve the Pandemic Fund’s transparency\, promote efficient fund distribution\, and enhance implementation effectiveness. In an era where donors demand fund accountability and recipient countries desire freedom from colonialist oversight mechanisms\, civil society’s role is crucial. This engagement is key to redefining and decolonizing global health financing accountability\, positioning it within the country with independent institutions. \nThe Rise of Anti-Science Disinformation and its Impact on Global Public Health \nThe rise of anti-science disinformation and its impact on global public health discusses the rise of targeted attacks against biomedical science and scientists\, especially in the areas of vaccinology and virology\, and how this will block global efforts at pandemic preparedness. How to overcome this through a combined approach of improved public health communications + directly combating sources of disinformation \nBuilding a Resilient Global Health Workforce: Training for the challenges ahead \nThe global health workforce faces unprecedented challenges\, from pandemics to evolving healthcare needs in a rapidly changing world. To address these challenges\, there is a pressing need to train a diverse and adaptable pool of health workers capable of meeting the demands of the future. This abstract introduces a panel which explores innovative approaches to prepare healthcare professionals for the complexities of modern healthcare delivery. Global health systems are strained by factors such as demographic shifts\, emerging diseases\, and health inequalities. To bridge these gaps\, transformative solutions are required. Training a diverse cadre of health workers is central to meeting this need and building resilience in health systems. This panel aims to spark a conversation on the vital role of training in building a resilient global health workforce that can effectively tackle the multifaceted challenges facing healthcare systems worldwide. \nStrengthening Global Health Security: Building bridges between civilians and the military \nThis panel aims to provide global health professionals at all levels with a comprehensive understanding of the pivotal role played by the defense and security sectors in Global Health Security (GHS). As health crises transcend borders and have impacts far beyond health\, it’s essential to grasp the nuanced contributions and considerations of these sectors within the evolving multilateralGHS framework. Our panelists will adeptly contextualize the capabilities and constraints of these sectors\, explore how civil-military collaboration in GHS is not merely reactionary but proactive\, and describe multifaceted strategies to ensure cohesive and effective multisectoral approaches to safeguarding global health. \n Leveraging Digital Learning in Health Emergencies for Health Equity \nIn the evolving landscape of health emergencies\, a system that rapidly equips frontline health workers with the necessary information and skills can significantly improve outcomes and save lives. Digital learning presents a unique opportunity to transcend geographic\, financial\, and political barriers to do just that. This panel discussion delves into the transformative potential of just-in-time digital learning in enhancing emergency preparedness and response to public health crises. Representatives from the World Health Organization (WHO) will share insights into global initiatives and the importance of standardized\, yet adaptable\, digital learning modules. Project ECHO\, an evidence-based telementoring initiative that leverages videoconferencing to connect specialists with the broader health workforce in real-time discussion\, epitomizes this potential of adaptable digital platforms. ECHO experts\, including representatives from Seed Global Health\, University of Nebraska Medical Center\, and University of Botswana\, will share how they leveraged the case-based ECHO learning model to rapidly engage thousands of frontline health workers in collaborative problem solving during the 2023 Sudan conflict\, Ukraine war\, 2022 Ebola outbreak\, and COVID-19 pandemic. Converging the perspectives of both WHO and Project ECHO\, this panel aims to create dialogue on the present capabilities and future potential of digital learning in bolstering public health resilience globally. \n Training the Next Generation of Global Health Researchers \nThe Fogarty Global Health Fellows and Scholars Program\, established in 2004\, has provided support to over 1\,600 trainees from the United States and Low- and Middle-Income Countries (LMICs). Seven consortia of U.S. academic institutions collaborate to offer these fellowships\, facilitating mentored research training in LMIC partner institutions. Research within the program spans diverse global health topics\, encompassing communicable diseases like HIV/AIDS\, non-communicable diseases\, mental health\, and more. In a 90-minute panel discussion\, program trainees will share insights into their research\, training experiences\, and career paths. The Fogarty International Center’s leadership will also reflect on the program’s impact and achievements. This discussion will unite distinguished alumni and current trainees of the NIH-Fogarty Global Health Program\, showcasing individuals with varying backgrounds\, including U.S. and international trainees\, MD and PhD fellows\, and representing different career stages. \nDiagnostic Testing and Imaging Services in Low- and Middle-Income Countries: Addressing supply chain and policy bottlenecks for equitable access \nWithin the realm of modern medicine\, appropriate diagnostic capacity is indispensable in guiding treatment. Nonetheless\, diagnostics and imaging technology\, in contrast to pharmaceuticals and vaccinations\, are often relegated to the periphery. Nowhere is the problem more acute than in low-and middle-income countries (LMICs). Despite recent investments directed towards enhancing health diagnostics and imaging\, their latent potential to confer substantial benefits and improved patient outcomes remains unrealized. LMICs must confront challenging and often inequitable supply-chain practices and an international\, geopolitical landscape with competing political agendas. This panel session will directly address the myriad of issues preventing equitable access to quality diagnostic testing and imaging services in LMICs. \nClimate Change as a Threat to Global Health & Human Rights \nThe inequitable health threats of climate change pose sweeping implications for health-related human rights\, especially in low- and middle-income countries\, with environmental degradation challenging the most fundamental conditions for human life and the individual dignity and rights of vulnerable populations and future generations. However\, international negotiations to mitigate emissions — from the 1992 United Nations Framework Convention on Climate Change and its 1997 Kyoto Protocol to the 2015 Paris Agreement — have realized limited success in addressing the health hazards caused by the unfolding climate crisis. This session frames the rapidly evolving state of discourse on public health and human rights in climate change debates — examining global governance efforts\, academic research\, NGO advocacy\, and youth engagement. This session addresses the synergies between global health\, human rights\, and climate justice\, with a focus on understanding the global health threats of anthropogenic climate change and identifying the human rights advancements necessary to frame international law reforms for mitigation and adaptation. \nHost institutions for CUGH 2024 are the National Cancer Institute (NCI)\, UCSF Institute for Global Health Sciences\, UW Department of Global Health\, and the USC Insitute on Inequalities in Global Health. \nPlease visit CUGH 2024 to register.
URL:https://globalbiodefense.com/event/cugh-2024-consortium-of-universities-for-global-health/
LOCATION:Westin Bonaventure Hotel and Suites\, 404 S Figueroa St\, Los Angeles\, California\, 90071\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240307T120000
DTEND;TZID=America/New_York:20240307T130000
DTSTAMP:20240301T203718Z
CREATED:20240301T203718Z
LAST-MODIFIED:20240301T203718Z
UID:60481-1709812800-1709816400@globalbiodefense.com
SUMMARY:Indoor Air and Infectious Disease Transmission
DESCRIPTION:The Institute for Pandemics (IfP) in collaboration with the Canadian Public Health Association presents a webinar for public health professionals to hear the latest research on indoor air transmission of infectious diseases and strategies to reduce exposure. \nThis webinar is a preview to the symposium\, “Something in the air: Towards a new understanding of aerosols and respiratory disease transmission”\, that will be presented at Public Health 2024 in Halifax this April. \nDr. Raymond Tellier will introduce the concept and definition of respiratory bioaerosols\, and review some of the abundant scientific evidence supporting an important role for aerosol transmission of influenza A virus and SARs-CoV-2 virus\, 2 agents with a proven pandemic capacity. \nDr. Sarah Haines will present her recent work on portable air cleaners to detect SARs-CoV-2 as well as identifying ventilation and other strategies that may be beneficial in reducing viral exposure. \nPlease visit the University of Toronto Institute for Pandemics’ Indoor Air and Infectious Disease Transmission event page to register.
URL:https://globalbiodefense.com/event/indoor-air-and-infectious-disease-transmission/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240310
DTEND;VALUE=DATE:20240315
DTSTAMP:20240112T174003Z
CREATED:20240112T174003Z
LAST-MODIFIED:20240112T174003Z
UID:59619-1710028800-1710460799@globalbiodefense.com
SUMMARY:CDC International Symposium on Biosafety 2024
DESCRIPTION:The 18th CDC International Symposium on Biosafety – Modernizing Biosafety Operations and Practices – will be held 10-14 March 2024 in Atlanta\, Georgia. \nThe symposium offers a showcase of the latest advancements in biosafety research\, interactive workshops to gain practical insights on applications\, expert insight on design and operation of biocontainment and animal facilities\, and behind-the-scene tours of the Emory Primate Center Field Research Station and CDC’s Emergency Operations Center Laboratory Training Facility. \nHighlighted conference topics and sessions include: \n\nModern Lab Design: A Success Story\nQuestions to Consider When Designing ABSL-3 Facilities\nABSL-3 Case Study\nImplementing ISO 35001\nWaste Management in Animal Facilities\nLatest in Biosafety Research\nPanel: Hiring\, Retention\, Worker Shortage\nAI’s Role in Biosafety Training\nSpaceflight Microbiology: Mitigating Health and Habitat Risks While Living and Working in Space\nPathogens of the Future\n\nPre-conference classes will be offered for all levels: \n\nBiosafety 101\nEstablishing Biosafety Levels in the Field\nReviewing Past Exposures to Improve Biosafety\nNavigating the Integration of Biosafety\, Biosecurity\, and Emergency Management\nRisky Business: Animal Biosafety Assessments\n\nPoster Abstracts are being accepted until 15 February 2024. \nPlease visit the Eagleson Institute’s CDC International Symposium on Biosafety page to register for this event.
URL:https://globalbiodefense.com/event/cdc-international-symposium-on-biosafety-2024/
LOCATION:Crown Plaza Ravinia\, 4355 Ashford Dunwoody Rd\, Atlanta\, GA\, 30346\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240310
DTEND;VALUE=DATE:20240315
DTSTAMP:20240301T213559Z
CREATED:20240301T213315Z
LAST-MODIFIED:20240301T213559Z
UID:60484-1710028800-1710460799@globalbiodefense.com
SUMMARY:SOT 2024 - Society of Toxicology Annual Meeting
DESCRIPTION:The 2024 Annual Meeting of the Society of Toxicology will gather more than 5\,000 toxicologists and related stakeholders for five days of Featured and Scientific Sessions\, 2000+ poster presentations\, networking events\, and the popular three-day ToxExpo. \nHighlighted session topics include: \n\nUpdate on the Development of Medical Countermeasures and Biomarkers against Pulmonary Chemical Threat Agents\nApproaches for Treatment of Nerve Agent Poisoning: From Experimental Laboratories to Intensive Care Units\nPhosgene Inhalation Injuries: Potential Medical Countermeasures and Biomarkers\nThe Göttingen Minipig for Medical Countermeasures Development: Benefits and Capabilities\nNix the Six: Strategies for Implementing Nonanimal Acute Toxicity Testing\nA Strategic Approach to Nonclinical Anti-Drug Antibody Assessment\nThe Evolution of BioTech into TechBio\nHigh-Throughput In Vitro—In Vivo Extrapolation for Predictive Toxicology\nEvaluation of Drug-Induced Liver Toxicity of Trovafloxacin in a Human Microphysiological Liver Model\nFoundations of Embryonic and Fetal Development and Application to Developmental Toxicity Testing\n‘Relax Immune System\,’ Cell and Gene Therapy Here\nPreclinical Development of RNA-Editing\, Gene\, and Cell Therapies: Risks and Challenges\nHepatoPRIME: Primary Human Hepatocytes for Superior Toxicology Assay Outcomes\nWeight of Evidence Analysis and Problem Formulation for Chemical Risk Assessment: Fundamental Principles and Application through Case Examples\nBenchmark Dose Modeling and Its Applications in Drug\, Food\, and Chemical Safety Evaluation and Assessment\nFeasibility Study of Long-Term Repeated Intracerebroventricular Administration in Cynomolgus Monkeys\nAI Will Only Replace Toxicologists Who Do Not Use It\nVariation in Seroprevalence of Adeno Associated Viruses (AAVs) Serotypes in Non-Human Primates (NHPs)\nBridge over Adverse Waters: Integrating Pathology Findings into the Interpretation of Toxicology Studies\nHarnessing Toxicology in Pregnancy: Traditional and Novel Approaches to Placental Toxicology Research\nPutting Theory into Practice: Using Computational New Approach Methodologies in Next-Generation Risk Assessment\nUse of New Approach Methodologies for the Assessment of Inhaled Substances: Examples and Case Studies\nNeurotoxicity and Neuroinflammation Profiles in Animal Models\nSerial Blood Sampling and Comparison of Three 91-day Continuous Intravenous Infusion Models in the Rat in Safety Assessment Studies\nA Current Prevalence Study for Laboratory Rodent Adventitious Infectious Agents\n\nPlease visit the SOT 2024 Annual Meeting website for more information.
URL:https://globalbiodefense.com/event/sot-2024-society-of-toxicology-annual-meeting/
LOCATION:Salt Palace Convention Center\, 100 S W Temple St\, Salt Lake City\, UT\, 84101\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240312
DTEND;VALUE=DATE:20240314
DTSTAMP:20240306T201823Z
CREATED:20240306T201823Z
LAST-MODIFIED:20240306T201823Z
UID:60520-1710201600-1710374399@globalbiodefense.com
SUMMARY:Resilient and Scalable MCM Ecosystem: WHO Coordination Meeting for Advancing Timely and Equitable Access
DESCRIPTION:The World Health Organization is convening representatives from regional entities on 12 – 13 March 2024 for an in-person meeting for a Resilient and Scalable MCM Ecosystem: Regional Entities Coordination Meeting for Advancing Timely and Equitable Access to Medical Countermeasures Against Pandemic Threats. \nThe impact of the COVID-19 pandemic highlighted collective vulnerabilities and the need to strengthen the international community’s preparedness to future pandemics. \nThe WHO-led interim coordination mechanism aims to enhance collaboration for timely and equitable access to medical countermeasures (MCM) against pandemic threats\, through a network-of-networks approach (i-MCM-Net) by leveraging existing networks in the global MCM ecosystem\, without prejudging or precluding INB and IHR discussions\, while awaiting the finalization of the INB deliberations. \nThe current focus of the i-MCM-Net is to understand how ready the world is in terms of equitable access to MCMs\, should a new pandemic threat emerge. Including to identify gaps and potential priority actions to improve readiness. \nWith a view to enhance coherence and foster synergies\, this meeting will provide an opportunity for the i-MCM-Net to provide an update on the analysis underway around Pandemic Influenza\, Novel Coronavirus and Disease X and to hear insights and perspectives on the analysis. \nExpected outcomes:\n\nEstablish cross-regional level communication channels and start an ongoing conversation among regional entities to improve collaboration for timely and fair access to MCM against pandemics.\nContribute input and feedback on the initial mapping of MCM (the i-MCM-Net mapping report)\, which will be further refined by May 2024.\nProvide input for a practical framework ensuring informed procedures for developing\, producing\, accessing\, allocating\, and deploying MCMs against pandemic threats.\n\nPlease visit the WHO’s Resilient and Scalable MCM Ecosystem: Regional Entities Coordination Meeting for Advancing Timely and Equitable Access to Medical Countermeasures Against Pandemic Threats website for more information.
URL:https://globalbiodefense.com/event/resilient-and-scalable-mcm-ecosystem-who-coordination-meeting-for-advancing-timely-and-equitable-access/
LOCATION:WHO Headquarters\, Geneva\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240312
DTEND;VALUE=DATE:20240318
DTSTAMP:20240106T184627Z
CREATED:20230422T184308Z
LAST-MODIFIED:20240106T184627Z
UID:57065-1710201600-1710719999@globalbiodefense.com
SUMMARY:2024 Fungal Genetics Conference
DESCRIPTION:The 2024 Fungal Genetics Conference\, the premier meeting for fungal genetics researchers\, will be held 12-17 March 2024 in Pacific Grove\, California \nThe Fungal Genetics Conference is the premier meeting for the international community of fungal geneticists. The conference features cutting-edge research spanning a diverse array of topics\, including comparative and functional genomics\, gene regulation\, cell biology\, biochemistry and metabolism\, population and evolutionary genetics\, host-pathogen interactions\, genetics education\, and more. \nThis is considered by many to be the pre-eminent meeting in this area and promotes interaction between researchers interested in medical pathogens\, plant pathogens\, saprobic fungi and symbiotic fungi. \n\nHighlighted topics and sessions include:\nFunctional genomics illuminates foundational biology and evolution\nNew technologies to understand and control antifungal resistance\nMultilevel regulatory circuits to understand fungal metabolism\nUnderneath\, within\, and around: pathogens and symbionts\nGenetic control of primary and secondary metabolism\nFungi at the cutting edge – microfluidics and other new tools\nMachine Learning in Fungal Genetics\nExperimental evolution with fungi\nInteractions of fungi with the biosphere\nMorphogenesis at multiple scales\nHorizontal gene transfer\, meiotic drive\, and related phenomena\nBiofilms\, biocontrol\, and disease prevention by genome engineering\nUnderstanding fungal pathogenesis by genomics\nSignaling in the gas phase\nPhase separation and sequestration\n\nA virtual attendance option is planned in addition to the in-person meeting. Virtual participant registration fees for full-time residents of any country with low- and middle-income economies will be waived. \nPlease visit the Genetics Society of America 2024 Fungal Genetics Conference website for more the latest information and to register.
URL:https://globalbiodefense.com/event/2024-fungal-genetics-conference/
LOCATION:Asilomar Conference Grounds\, 800 Asilomar Ave\, Pacific Grove\, CA\, 93950\, United States
CATEGORIES:Conference
ORGANIZER;CN="Genetics Society of America":MAILTO:society@genetics-gsa.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240313
DTEND;VALUE=DATE:20240316
DTSTAMP:20240306T223831Z
CREATED:20240306T221528Z
LAST-MODIFIED:20240306T223831Z
UID:60523-1710288000-1710547199@globalbiodefense.com
SUMMARY:Antimicrobial Resistance – Genomes\, Big Data and Emerging Technologies
DESCRIPTION:Wellcome Genome Campus will host Antimicrobial Resistance – Genomes\, Big Data and Emerging Technologies on 13-15 March 2024 in Hinxton\, UK with onsite or virtual attendance. \nThis year’s programme will once again focus on genomic evidence and how to implement it in clinical practice and policy for antimicrobial resistance (AMR) control. The meeting will highlight the advances in machine learning\, AI and computational tools to predict AMR. We will also discuss how to build an international genomics infrastructure to tackle AMR and emerging lessons from other global public health issues. \nAMR is a major challenge in our globalised world\, and tackling it will take the combined resources and effort of researchers working across different disciplines. Technical advances in recent years continue to expand our ability to collect vast amounts of genomic information on pathogens\, and a wealth of data is being collected in epidemiological and surveillance studies\, including on the socio-economic burden of AMR. \nDiscussions will focus on a variety of exciting topics\, including: \n\nGenomic surveillance of priority pathogens\nGlobal public health pathogen genomics infrastructure\nTranslation and implementation of genomics for AMR control\nWastewater surveillance\nAI\, machine learning\, and big data tools\nMeasuring the burden of AMR\n\nPlease visit the Antimicrobial Resistance – Genomes\, Big Data and Emerging Technologies event page for more information.
URL:https://globalbiodefense.com/event/antimicrobial-resistance-genomes-big-data-and-emerging-technologies/
LOCATION:Wellcome Genome Campus\, Hinxton\, CB10 1SA\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240313T090000
DTEND;TZID=America/New_York:20240313T100000
DTSTAMP:20240306T193945Z
CREATED:20240306T193721Z
LAST-MODIFIED:20240306T193945Z
UID:60515-1710320400-1710324000@globalbiodefense.com
SUMMARY:FMD Vaccine Availability in Africa and Prospects for Improved FMD Control
DESCRIPTION:Join the Global Foot-and-Mouth Disease Research Alliance (GFRA) for their Research Webinar series with Professor Baptise Dungu on 13 March 2024. \nProfessor Dungu will present on the status of FMD vaccine availability in Africa and prospects for improved FMD control through vaccination. \nThis 1-hour webinar will feature Professor Dungu’s 30-minute presentation followed by a 30-minute moderated Q&A session. \nThis series of research webinars presented by the GFRA is inspired by our networking philosophy. This online event series contributes to the continuous professional development of stakeholders at the cutting edge of new ideas and developments in Foot-and-Mouth Disease research. \nThere is no charge for this webinar but registration is required.
URL:https://globalbiodefense.com/event/fmd-vaccine-availability-in-africa-and-prospects-for-improved-fmd-control/
LOCATION:https://crdfglobal.zoom.us/webinar/register/WN_utw1EgMLQFWO5nOgnLP6RQ#/registration
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240314T120000
DTEND;TZID=America/New_York:20240314T130000
DTSTAMP:20240214T233849Z
CREATED:20240214T190847Z
LAST-MODIFIED:20240214T233849Z
UID:59970-1710417600-1710421200@globalbiodefense.com
SUMMARY:GMU Schar School Master of Biodefense Information Session
DESCRIPTION:The George Mason University (GMU) Schar School of Policy and Government will be hosting a Master of Biodefense Information Session on Thursday\, March 14\, noon to 1:00 p.m. ET (Virtual). \nProspective students are invited to attend to hear more about the Master of Biodefense program offered at the Schar School of Policy and Government at George Mason University. \nLearn more about the program\, application process\, student experience\, and graduate outcomes. The program is offered in part-time\, full-time\, online\, in-person\, and hybrid formats. \n Learn more and register for the information session. \nGlobal Biodefense is an official media partner of the GMU Schar School of Policy and Government.
URL:https://globalbiodefense.com/event/gmu-schar-school-master-of-biodefense-information-session/
LOCATION:
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2024/02/gmu-schar-school-ms-biodefense-1200.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240315T100000
DTEND;TZID=America/Los_Angeles:20240315T110000
DTSTAMP:20240301T221921Z
CREATED:20240301T221921Z
LAST-MODIFIED:20240301T221921Z
UID:60491-1710496800-1710500400@globalbiodefense.com
SUMMARY:Introduction to the 2024 Joint Commission Standards for Infection Control
DESCRIPTION:Beginning this summer\, hospitals looking to maintain or apply for accreditation from The Joint Commission—the nation’s oldest and largest standards-setting and accrediting body in health care—will have to adopt a new set of standards for high-consequence infectious diseases (HCID). \nJoin NETEC for an exploration of the new infection control requirements established by the Joint Commission\, the nation’s oldest and largest standards-setting and accrediting body in health care. Panelists will review key changes to the standards\, which will go into effect July 1\, 2024\, and identify strategies for implementation and compliance. Resources and tools will be shared to empower your organization to help prepare for the new standards by July 2024. \nThis webinar is for health care professionals who will implement and/or provide training on these new standards including\, quality improvement teams​\, emergency managers\, infection preventionists\, hospital epidemiologists\, educational specialists\, nurse educators\, and coordinators for physician education. \nThe webinar is free and open to all health care professionals\, especially quality improvement teams\, emergency managers\, infection preventionists\, hospital epidemiologists\, educational specialists\, nurse educators\, and coordinators for physician education. \nPlease visit NETEC’s Introduction to the 2024 Joint Commission Standards for Infection Control to register. \nNETEC is a collaborative effort of 13 U.S. Regional Emerging Special Pathogen Treatment Centers (RESPTCs) working together to enhance the capacity of the U.S. public health and health care systems to manage special pathogens safely and effectively. Visit the NETEC website to access a wide range of special pathogen resources\, request free readiness consulting and assessment\, or ask your questions related to special pathogens readiness\, response\, or patient care.
URL:https://globalbiodefense.com/event/introduction-to-the-2024-joint-commission-standards-for-infection-control/
LOCATION:MO
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240315T143000
DTEND;TZID=Europe/Paris:20240315T160000
DTSTAMP:20240306T225301Z
CREATED:20240306T223149Z
LAST-MODIFIED:20240306T225301Z
UID:60528-1710513000-1710518400@globalbiodefense.com
SUMMARY:COMBINE Webinar on Developing Target Product Profiles for Antibiotics
DESCRIPTION:The AMR Accelerator programme will host a COMBINE Webinar on Developing Target Product Profiles for Antibiotics on 15 March 2024. \nDecisions on disease targets and whether to aim for oral or intravenous administration of a new compound requires complex decisions\, involving the desires\, needs and expectations of patients\, healthcare organisations and regulators across the globe. \nDeveloping Target Product Profiles (TPP) is a challenge for antibiotics development. In this webinar\, speakers from CARB-X\, Evotec and GSK will discuss TPPs in relation to aims\, timing\, scope and flexibility. The discussion will discuss the need for TPPs across the development life-cycle: from drug discovery to clinical trials\, taking into account both clinical pathways\, the area of application and market considerations. \nPlease visit the COMBINE Webinar on Developing Target Product Profiles for Antibiotics event page for more information.
URL:https://globalbiodefense.com/event/combine-webinar-on-developing-target-product-profiles-for-antibiotics/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240317
DTEND;VALUE=DATE:20240323
DTSTAMP:20240306T224549Z
CREATED:20240306T224549Z
LAST-MODIFIED:20240306T224549Z
UID:60531-1710633600-1711151999@globalbiodefense.com
SUMMARY:Innovative Approaches in Antibacterial Research and Development to Fight the Antibiotic Resistance Crisis
DESCRIPTION:Innovative Approaches in Antibacterial Research and Development to Fight the Antibiotic Resistance Crisis will take place 17-22 March 2024 in Ventura\, CA. \nThe antibiotic resistance crisis is among us\, and with it\, the urgent need to tackle this global health threat has never been greater. Yet each step in the discovery and development process\, from target validation and inhibitor optimization to clinical trial design and product commercialization\, poses formidable challenges. The New Antibacterial Discovery and Development GCR will turn these challenges into opportunities to promote interdisciplinary innovation while addressing the global need for more effective antibiotic therapies. \nThe conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide\, concentrating on the latest developments in the field. \nHighlighted sessions include: \n\nDiscovering Mechanistically Novel Antibacterial Leads through Phenotypic Screening\nAntisense Antibiotics as Precision Therapeutics for Pseudomonas aeruginosa\nAddressing Antimicrobial Resistance in Clostridioides difficile: Clinical Implications and the Motivation for Novel Treatment Approaches\nBiasing Bacteriophage Behaviours\nAntibiotics Preorganized for Ribosomal Binding Overcome Antimicrobial Resistance\nHost Directed Therapy Against Mycobacterial Infections\nGARDP: Working Globally to Address the Antimicrobial Resistance Crisis\nBeta-lactamases and Skaters: Pairs and Singles\nDevelopment of Broad-Spectrum MBL Inhibitors\nSystems Chemical Biology Approach to Antibiotic Discovery\nMacrocyclic Peptides Disassemble the Periplasmic LPS Transport Bridge: New Approaches to Kill Multidrug-Resistant Gram-Negative Bacteria\nCracking Nature’s Recipes to Design Lipid-Targeting Antibiotics\nChallenges of Antibacterial Discovery\nGenerative Artificial Intelligence for Antibiotic Discovery\nMulti-Drug Resistant (MDR) Pathogens Are Driving the Need for New Novel Antibacterials\nReviving Natural Products Antibiotic Discovery\n\nPlease visit the Gordon Research Conference’s Innovative Approaches in Antibacterial Research and Development to Fight the Antibiotic Resistance Crisis website for more information.
URL:https://globalbiodefense.com/event/innovative-approaches-in-antibacterial-research-and-development-to-fight-the-antibiotic-resistance-crisis/
LOCATION:Ventura Beach Marriott\, 2055 Harbor Boulevard\, 2055 E Harbor Blvd\,\, CA\, 93001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240319
DTEND;VALUE=DATE:20240322
DTSTAMP:20240126T220904Z
CREATED:20240126T220646Z
LAST-MODIFIED:20240126T220904Z
UID:59709-1710806400-1711065599@globalbiodefense.com
SUMMARY:2024 CBRNE Research & Innovation Conference
DESCRIPTION:The 2024 CBRNE Research & Innovation International Conference will take place 19-21 March\, 2024 in Strasbourg\, France. \nCBRNE R&I 2024 will gather stakeholders to discuss topics of CBRNE detection\, protection\, decontamination\, depollution\, medical countermeasures\, diagnostic tools\, epidemiology\, forensic sciences\, and risks & crisis management. Demonstrations are planned from the French & German Committee (including responders from the Fire Brigades\, Emergency Medical Services\, Police\, Gendarmerie\, bomb disposal experts) and scientists from the University of Strasbourg. \nHighlighted workshops and sessions include: \n\nTools to inform health personnel on the detection of highly contagious patients\nBiotoxins analysis (overview of the different exercises on this topic\, discussion on the detection and identification method used by the participants of the round-table for on-site and off-site analysis\, identify the gaps/needs\, future works)\nOn-site chemical detection : crossing the methods and tools to identify solids and liquids\nGas and liquid effluents from lithium batteries : risks assessment\nPersonal decontamination\nProtection: Are current test methods appropriate for evaluating protective clothing?\nDrug detection: detection and training issues\nManagement of accidental pollutions and their consequences\nThe action of canine teams in the face of the CBRNe threats\nTox COM : gestural communication in the warm zone\nCBRN training in a virtual environment\nPediatric CBRNE casualty care considerations\nUse of new technologies in the CBRNe threat assessment : robots and drones\nOn-site radiological detection : limitations and innovations\nEducation on human factors to improve the reliability of operations\n\nPlease visit the 2024 CBRNE Research & Innovation International Conference website for more information and to register.
URL:https://globalbiodefense.com/event/2024-cbrne-research-innovation-conference/
LOCATION:Palais de la Musique & des Congrès\, Palais des Congrès\, Pl. de Bordeaux\, Strasbourg\, 67000\, France
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240319
DTEND;VALUE=DATE:20240322
DTSTAMP:20240206T191913Z
CREATED:20240206T191817Z
LAST-MODIFIED:20240206T191913Z
UID:59923-1710806400-1711065599@globalbiodefense.com
SUMMARY:Bioprocessing Summit Europe 2024
DESCRIPTION:The 7th Annual Bioprocessing Summit Europe will be held 19-21 March 2024 in Barcelona\, Spain and through online participation. \nHighlighted sessions and seminars include: \n\nWhat Have Monoclonal Antibodies Ever Done for Us? Past\, Present\, and Future Perspectives on Antibodies and How They Have Driven Bioprocessing Progress\nLab-on-a-Chip and Microfluidic Technologies in Nanomedicine\nA Universal Tool for Stability Predictions of Biotherapeutics\, Vaccines\, and in vitro Diagnostic Products\nHost Cell Protein Monitoring in AAV-Based Gene Therapy Products Using LC-MS/MS\nThe Technical Challenges of Developing Monoclonal Antibodies against Snake Venoms\npH-Independent Potential-Controlled Antibody Purification\nDesign and Discovery of Affinity and Mixed-Mode Adsorbents\nNovel Approaches in an Efficient Affinity Chromatography Strategy for Your Antibody Variants & Recombinant Proteins\nPredicting and Increasing the Long-Term Stability of Lyophilised mAb Solutions Based on Water Activity\n3D-Printed Devices for Biopurifications\nTowards Continuous Bioproduction—Integration of Microfluidic Systems into Small-Scale Bioreactors\nUpstream Modelling Toolbox for Monoclonal Antibody (mAb) Process Development\nManufacturing Strategy for Recombinant Proteins Expressed in Microbials\nEvaluating Analytical Strategies to Quantify Capsid Titre: Towards a Platform-Method Approach to Accelerate AAV Drug Product Development\nAccelerating AAV process development and release testing with a walk-away immunoassay platform\n\nPlease visit Cambridge Healthtech Institute’s Bioprocessing Summit Europe 2024 website for more information and to register.
URL:https://globalbiodefense.com/event/bioprocessing-summit-europe-2024/
LOCATION:Intercontinental Barcelona\, Av. de Rius i Taulet 3\, Barcelona\, 08004\, Spain
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240321
DTEND;VALUE=DATE:20240324
DTSTAMP:20240126T213623Z
CREATED:20230908T140853Z
LAST-MODIFIED:20240126T213623Z
UID:59069-1710979200-1711238399@globalbiodefense.com
SUMMARY:ASPPH 2024 Annual Meeting
DESCRIPTION:The 2024 ASPPH Annual Meeting for Academic Public Health is March 21-23\, 2024 in Arlington\, Virginia. \nThe Annual Meeting convenes graduate and undergraduate academic public health leaders\, faculty\, students\, and members of the public health community from around the world to research in public health. We are committed to presenting timely\, relevant sessions and information and facilitating essential discussions that advance our shared mission of creating a healthier world. \nNetwork with academic public health leaders\, students\, and faculty; public health partners from the government; fellow association members; and foundation leaders and sponsors of academic public health initiatives. \nThe meeting will be held all day on Thursday\, March 21 and Friday\, March 22 with optional skill-building workshops on Saturday\, March 23 from 8:00 AM – 11:00 AM ET. \nTaking place Friday\, March 22 at 9:00 AM ET\, Dr. Lisa Cooper\, Bloomberg Distinguished Professor\, Johns Hopkins Bloomberg School of Public Health\, and author of Why Are Health Disparities Everyone’s Problem\, will provide opening remarks. An inter-sectoral panel discussion will follow with representatives from academia\, government\, and industry discussing the role of their respective disciplines in advancing knowledge and understanding of health disparities and identifying mechanisms to improve minority health and reduce health disparities. This session aims to foster a deeper understanding of the challenges at hand and inspire collaborative solutions. \nPlease visit the 2024 ASPPH Annual Meeting website for more information.
URL:https://globalbiodefense.com/event/aspph-2024-annual-meeting/
LOCATION:Crystal Gateway Marriott\, 1700 Jefferson Davis Highway\, Arlington\, VA\, 22202\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240324
DTEND;VALUE=DATE:20240325
DTSTAMP:20240206T190625Z
CREATED:20240206T190625Z
LAST-MODIFIED:20240206T190625Z
UID:59891-1711238400-1711324799@globalbiodefense.com
SUMMARY:Radiological and Nuclear Preparedness and Response Workshop
DESCRIPTION:NACCHO\, in collaboration with the Centers for Disease Control and Prevention (CDC) and other state and local partners\, is hosting a full day  radiological/nuclear preparedness and response workshop for about 70 attendances on 24 March 2024 in Cleveland\, Ohio. \nThis is a pre-conference workshop prior to NACCHO’s Preparedness Summit\, taking place 25-28 March 2024. The Preparedness Summit is a one-of-a-kind learning and networking opportunity for local health officials and their public health partners from all geographic regions of the nation to share perspectives and engage in dialogue on common key public health practice issues. \nThis interactive workshop’s first aim is to offer justification for why robust radiation planning and exercising are essential while also providing resources currently used by emergency and public health planners to bridge knowledge gaps and improve their existing radiation planning and exercising programs. The second aim of the workshop is to introduce and train public health preparedness planners to facilitate a new CDC tool called TEST (Training and Exercise Simulation Tool) which is a collaborative serious game that was developed to bridge the gap between discussion and operational exercises for Community Reception Centers (CRCs) using narrative-based problems to foster teamwork\, resource management and understanding of specific roles and responsibilities during a radiation emergency. \nPlease note that due to funding and space restrictions\, we may not be able to accommodate all requests. We will make every effort to include as many applicants as possible and will ensure a diversity of representation across the country. Your answers to the questions below will assist us in this process. \nInformation gained from this workshop will help inform future NACCHO communications plans and corresponding promotional activities that highlight resources of most need. \nPlease visit NACCHO’s Radiological and Nuclear Preparedness and Response Workshop for more information and to register to attend.
URL:https://globalbiodefense.com/event/radiological-and-nuclear-preparedness-and-response-workshop/
LOCATION:Huntington Convetion Center of Cleveland\, 300 Lakeside Avenue\, Cleveland\, OH\, 44113\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240325
DTEND;VALUE=DATE:20240329
DTSTAMP:20240306T231313Z
CREATED:20240306T231313Z
LAST-MODIFIED:20240306T231313Z
UID:60533-1711324800-1711670399@globalbiodefense.com
SUMMARY:Preparedness Summit 2024
DESCRIPTION:The 2024 Preparedness Summit will be held 25-28 March 2024 in Cleveland\, Ohio. \nJoin more than 2\,500 attendees—who work in all levels of the government (federal\, state\, and local)\, emergency management\, volunteer organizations\, healthcare coalitions\, and academia—to share best practices\, build partnerships\, advance your skills\, and take away innovative solutions and practical strategies to address the vulnerabilities in our country’s health security system. \nHighlighted sessions include: \n\nAdvancing anthrax preparedness: Strengthening national defense against biological threats through cross-agency collaboration\nThe vital role of public health laboratories in response to surge events\nBioterrorism risk communications: Where are we now?\nPediatric concerns in a large-scale\, multi-state chemical\, biological\, radiological\, nuclear\, and explosive (CBRNE) mass casualty incident\nTularemia Emergency Response: Clinical Guidelines for Treatment and Prophylaxis After Intentional Release or Naturally Occurring Outbreaks of Francisella tularensis\nMedical toxicology and public health: A fruitful partnership illustrated by a popular awareness level course on chemical threats\nA National Special Pathogen System (NSPS) of care: Defining and expanding the structure for a more coordinated response to high consequence infectious diseases\nRegulatory framework for medical countermeasures response: Lessons from the expanded access programs for mpox therapeutics\nOperationalizing an early response framework for public health emergencies\nCultivating resilient public-clinical health networks to protect against infectious disease outbreaks\nBringing special pathogen care home: Virtual assessment model for at-home evaluation of suspected high-consequence infectious disease cases\nChaos to Clarity: The Post COVID-19 Transition\nEnhancing public health at the border: Mass vaccination initiatives\nAdvancing equity in mpox and COVID-19 diagnostics: Rapid summary of priority actions\nEnhancing state infectious disease preparedness and response capabilities for future threats via a discovery hub: INSPIRE: Readiness\nCHEMPACK program: Nerve agent antidotes\nPandemic Preparedness Training for Small Businesses\nPreparedness epidemiology: A local perspective\nMaking sense of the system: A One Health-based approach to assessing risk\, prioritizing action\, and building resilience\nWorking with the community to respond to a tripledemic of hepatitis A\, meningococcal disease\, and mpox affecting the same at-risk populations in Orange County\nA Case Study in Collaboration: Public Health\, Healthcare\, and Emergency Management Response to the East Palestine\, Ohio Train Derailment\nAdvancing national all-hazards hospital situational awareness\nFrom sewage to solutions: The possibilities and implications of wastewater monitoring\n\nA pre-conference workshop on Radiological and Nuclear Preparedness and Response will be held on 24 March 2024. \nPlease visit the 2024 Preparedness Summit website for more information and to register to attend.
URL:https://globalbiodefense.com/event/preparedness-summit-2024/
LOCATION:Huntington Convetion Center of Cleveland\, 300 Lakeside Avenue\, Cleveland\, OH\, 44113\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240325
DTEND;VALUE=DATE:20240329
DTSTAMP:20240307T004102Z
CREATED:20240307T004026Z
LAST-MODIFIED:20240307T004102Z
UID:60536-1711324800-1711670399@globalbiodefense.com
SUMMARY:20th Meeting of the Vector Control Advisory Group (VCAG)
DESCRIPTION:The 20th Meeting of the World Health Organization’s Vector Control Advisory Group (VCAG) will be held 25 March 2024 via online participation. \nHighlighted agenda items include: \n\nAedes SIT\nSpatial repellents\nTopical repellents\nVCAG operation\n\nThe sessions are for VCAG members or invitees only. \nAbout the VCAG \nAn independent evaluation of the public health value of innovative new tools\, technologies and approaches for vector control is needed to enable WHO to provide evidence-based advice to Member States on whether their deployment is justified. This is essential to ensure that scarce resources available for disease control are used to maximum impact. In order to assist WHO in developing public health policy on new tools\, the Vector Control Advisory Group (VCAG) assesses the public health value of new interventions and provides guidance on developing the evidence base required to inform such assessments. \nRead the report from the prior meeting of the VCAG in September 2023. \nPlease visit the WHO’s 20th Meeting of the Vector Control Advisory Group (VCAG) page for more information.
URL:https://globalbiodefense.com/event/20th-meeting-of-the-vector-control-advisory-group-vcag/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240329
DTSTAMP:20240206T194536Z
CREATED:20240206T194536Z
LAST-MODIFIED:20240206T194536Z
UID:59929-1711411200-1711670399@globalbiodefense.com
SUMMARY:Precision Med TRI-CON 2024
DESCRIPTION:The 31st International Precision Med TRI-CON 2024 will be held 26-28 March 2024 in San Diego\, California. \nVirtual participation is available as well as flexible registration to switch between in-person and virtual attendance across the conference. \nJoin thousands of international thought leaders to discuss the latest research\, technologies\, innovation and business models in implementing precision medicine\, biomarkers and companion diagnostics\, genomic medicine\, and precision health; innovation and market access strategies for at-home diagnostics\, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology\, including Multi-Cancer Early Detection and Minimal Residual Disease testing. \nEmerging implications of faster and cheaper sequencing\, AI and digital tools\, and spatial biology and single-cell multiomics in advancing precision medicine will be covered in 2024. \nHighlighted sessions and topics include: \n\nThe Shifting Landscape of Respiratory Pathogen Testing\nMultiplex Testing for Respiratory Pathogens—What Is the Right Fit?\nControlled Human Infection Models in Biomarker Development for Precision Medicine\nThe Host Response in Acute Infections and Sepsis: Potential Challenges and Benefits\nClinical Metagenomic Sequencing for Rapid Diagnosis of Infections\nDiagnostic Stewardship and Implementation of New Tests for Infectious Diseases in the Emergency Department\nDiagnosis of Invasive Fungal Infections by Microbial Metagenomics Sequencing\nAdvancing the AI in Diagnostics and Healthcare: Role of the Public-Private Partnership Model\nAugmenting AI-Powered Clinician Decision Support Tools for Severe Infection\nClinical Integration of Microbial Whole-Genome Sequencing\nHigh-Resolution Single-Cell and Spatial Technologies in Drug Development\nHome Testing for Infectious Diseases and Chronic Disease Monitoring\nScalable Solutions for Antibody Development and Manufacturing\nAccelerating Patient-Centered Diagnostics by Bringing Innovative Molecular Technologies to Point-of-Care Testing\nAt-Home Blood Microsampling: Innovations\, Opportunities\, and Challenges\nDirect Access Testing—What Can Be Done to Realize Its Full Potential?\nAdvances in Mobile and Digital Technologies for Point-of-Care Diagnostics\nRADically Speeding the Development and Validation of POC and Home-Based Diagnostics at the NIH: Lessons Learned and Future Directions\n\nPlease visit Cambridge Healthtech Institute’s Precision Med TRI-CON 2024 event page for more information and to register.
URL:https://globalbiodefense.com/event/precision-med-tri-con-2024/
LOCATION:Hilton San Diego Bayfront\, 1 Park Boulevard\, San Diego\, CA\, 92101-7897\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240401
DTEND;VALUE=DATE:20240405
DTSTAMP:20240206T233823Z
CREATED:20240206T233823Z
LAST-MODIFIED:20240206T233823Z
UID:59932-1711929600-1712275199@globalbiodefense.com
SUMMARY:World Vaccine Congress Washington 2024
DESCRIPTION:The World Vaccine Congress Washington 2024 will take place 1-4 April in Washington\, D.C. \nFrom basic research to commercial manufacture\, this one meeting covers the​ whole vaccine value chain where science\, government and manufacturers all come together to create ground- breaking progress.​ \nHighlighted sessions and topics include: \n\nGlobal Health mABs\nBiodefense & Preparedness Workshop\nVaccine Technology Workshop\nSpecial populations in clinical trials\nWhat are international agencies and industry doing to promote a One Health approach to global health risks\nAMR Workshop: Role of vaccines\, mABs\, phages and antibiotics\nPreparation of the CEPI Centralized Laboratory Network for Future Outbreaks\nRNA Workshop: From vaccines to therapeutics\nVaccine Delivery Workshop\nBiodegradable Lipid Nanoparticles for mRNA Vaccines with Room Temperature Stability\nInnovating vaccine development and implementation for impact\nSmallpox and Mpox live nonreplicating vaccine\nGlobal Health Workshop (NTDs)\nDeveloping novel partnership model for vaccines in EID\nImmune profiling: Building translational tools to improve mRNA vaccine performance\nVaccine manufacturing insights from Asia: Strengthening vaccine production capacity and capabilities\nChikungunya vaccine candidate\nThe evolving role of the ACIP\nThe future of COVID-19 vaccinations. Should we be developing broadly protective antigens or combinational vaccines?\nMonoclonal antibodies for prophylaxis of infectious disease\nWhat is the burden and uptake for RSV vaccines?\nThe future of global health: How to Advance detection and response capacity for Emerging & Re-emerging Pathogens in Africa & LMICs\nDecentralized trial solutions to improve access and health equity\nEmerging & re-emerging zoonotic diseases: what are our priority pathogens for spill over & pandemic risk?\nStudies to investigate the non-specific effects of vaccines and their importance in HICs and LMICs\nAn agile approach to PBMC collection in Vaccine Trials\nNirsevimab\, a monoclonal antibody for protection of all infants from RSV\n\nPlease visit the World Vaccine Congress Washington 2024 event site for more information and to register.
URL:https://globalbiodefense.com/event/world-vaccine-congress-washington-2024/
LOCATION:Walter E. Washington Convention Center\,  801 Mt Vernon Pl NW\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240402T130000
DTEND;TZID=America/New_York:20240402T143000
DTSTAMP:20240307T005932Z
CREATED:20240307T005932Z
LAST-MODIFIED:20240307T005932Z
UID:60538-1712062800-1712068200@globalbiodefense.com
SUMMARY:Uncertainty\, Trust\, and the Future of Public Health Communication
DESCRIPTION:A seminar on Uncertainty\, Trust\, and the Future of Public Health Communication will be held on 2 April 2024 online from 1:00-2:30 ET. \nThis program will explore public health communication in the context of a post – acute COVID world. How can we more effectively communicate public health messaging across different populations? What are the consequences of misinformation? How can we mitigate disinformation and disseminate accurate information to promote better health for all? \nThis event is cohosted by the Boston University School of Public Health and the BU College of Communication. \nPlease visit BU School of Public Health’s Uncertainty\, Trust\, and the Future of Public Health Communication to register.
URL:https://globalbiodefense.com/event/uncertainty-trust-and-the-future-of-public-health-communication/
LOCATION:
END:VEVENT
END:VCALENDAR